ACUTE MYELOID LEUKAEMIA (AML)
Clinical trials for ACUTE MYELOID LEUKAEMIA (AML) explained in plain language.
Never miss a new study
Get alerted when new ACUTE MYELOID LEUKAEMIA (AML) trials appear
Sign up with your email to follow new studies for ACUTE MYELOID LEUKAEMIA (AML), keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
New hope for tough leukemia: experimental drug combo aims for remission
Disease control Recruiting nowThis study tests a new drug, L-Annamycin, combined with standard chemotherapy (cytarabine) in adults whose acute myeloid leukemia (AML) has returned or not responded to one prior treatment. The goal is to see if the new combination can achieve complete remission (no signs of canc…
Matched conditions: ACUTE MYELOID LEUKAEMIA (AML)
Phase: PHASE2, PHASE3 • Sponsor: Moleculin Biotech, Inc. • Aim: Disease control
Last updated May 19, 2026 11:59 UTC
-
New triple therapy aims to wipe out lingering leukemia cells
Disease control Recruiting nowThis study tests a combination of three drugs (tagraxofusp, azacitidine, and venetoclax) in adults with acute myeloid leukemia (AML) who are in remission but still have tiny amounts of cancer cells that can't be seen under a microscope. The goal is to see if the treatment can saf…
Matched conditions: ACUTE MYELOID LEUKAEMIA (AML)
Phase: PHASE1, PHASE2 • Sponsor: Jacqueline Garcia, MD • Aim: Disease control
Last updated May 19, 2026 11:48 UTC
-
New combo aims to keep leukemia at bay after remission
Disease control Recruiting nowThis study tests whether a combination of two drugs (cytarabine and venetoclax) can help adults with acute myeloid leukemia (AML) stay in remission longer. Participants are 18 to 60 years old who achieved complete remission after chemotherapy but cannot get a bone marrow transpla…
Matched conditions: ACUTE MYELOID LEUKAEMIA (AML)
Phase: NA • Sponsor: Sohag University • Aim: Disease control
Last updated May 18, 2026 12:12 UTC
-
Scientists hunt for clues in blood to improve cancer care
Knowledge-focused Recruiting nowThis study is collecting blood and leftover tissue samples from 550 people with acute myeloid leukemia or follicular lymphoma. Researchers will analyze the samples to find genetic markers that may predict how well treatments work or why they stop working. The goal is to better un…
Matched conditions: ACUTE MYELOID LEUKAEMIA (AML)
Sponsor: Tempus AI • Aim: Knowledge-focused
Last updated May 26, 2026 08:27 UTC